Cargando…

Prevalence and antifungal susceptibility of gastrointestinal candidiasis among diabetic patients: A cross-sectional study

BACKGROUND: Gastrointestinal candidiasis is the most predominant opportunistic human mycosis, especially in diabetic patients. There is a global increase in antifungal resistance coupled with a rarity of information on antifungal susceptibility profiles in Uganda. OBJECTIVE: This study aimed to dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oyom, Anthony P., Okello, Emmanuel, Acam, Victoria, Aramo, Christine, Mwambi, Bashir, Okiria, John C., Oyet, Caesar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736660/ https://www.ncbi.nlm.nih.gov/pubmed/33354526 http://dx.doi.org/10.4102/ajlm.v9i1.997

Ejemplares similares

Assessing the prevalence and risk factors of pre-diabetes among the community of Iganga municipality, Uganda: a cross sectional study
por: Aramo, Christine, et al.
Publicado: (2019)

Common uropathogens among diabetic patients with urinary tract infection at Jinja Regional Referral Hospital, Uganda
por: Nabaigwa, Barbara I., et al.
Publicado: (2017)

Prevalence of Anemia and Its Associated Socio-Demographic Factors Among Pregnant Women Attending an Antenatal Care Clinic at Kisugu Health Center IV, Makindye Division, Kampala, Uganda
por: Mahamoud, Naimo Khalif, et al.
Publicado: (2020)

Prevalence of RhD variants among blood donors at Gulu Regional Blood Bank, Gulu, Northern Uganda
por: Ojok, Polycarp, et al.
Publicado: (2017)

Prevalence, morphological characterization, and associated factors of anemia among children below 5 years of age attending St. Mary’s Hospital Lacor, Gulu District, Northern Uganda
por: Ocan, Apollo, et al.
Publicado: (2018)

Candidiasis in Pediatrics; Identification and In vitro Antifungal Susceptibility of the Clinical Isolates
por: Mohammadi, R, et al.
Publicado: (2016)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates
por: Waikhom, Sayanika Devi, et al.
Publicado: (2020)

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
por: Shi, Yu, et al.
Publicado: (2020)

Candidiasis and Mechanisms of Antifungal Resistance
por: Bhattacharya, Somanon, et al.
Publicado: (2020)

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
por: Shi, Yu, et al.
Publicado: (2022)

In vitro antifungal susceptibility pattern of Candida species isolated from gastroesophageal candidiasis
por: Mirshekar, Mohsen, et al.
Publicado: (2021)

Epidemiology and antifungal resistance in invasive candidiasis
por: Rodloff, AC, et al.
Publicado: (2011)

Antifungal Susceptibility Testing with Etest for Candida Species Isolated from Patients with Oral Candidiasis
por: Song, You Bum, et al.
Publicado: (2015)

Pulmonary Candidiasis Associated with COVID-19: Evaluation of Causative Agents and their Antifungal Susceptibility Patterns
por: Shirvani, Fariba, et al.
Publicado: (2021)

Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis
por: Moges, Birhan, et al.
Publicado: (2016)

Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis
por: Jafarian, Hadis, et al.
Publicado: (2021)

Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis
por: Parslow, Ben Y., et al.
Publicado: (2022)

Conventional and alternative antifungal therapies to oral candidiasis
por: Anibal, Paula Cristina, et al.
Publicado: (2010)

Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis
por: Nejat, Ziba Abbasi, et al.
Publicado: (2018)

Characterization of Candida species isolated from vulvovaginal candidiasis by MALDI-TOF with in vitro antifungal susceptibility profiles
por: Aslani, Narges, et al.
Publicado: (2021)

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023)

Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China
por: Zeng, Zhang-rui, et al.
Publicado: (2019)

Propranolol Ameliorates the Antifungal Activity of Azoles in Invasive Candidiasis
por: Mayandi, Venkatesh, et al.
Publicado: (2023)

808. Outcomes of Invasive Candidiasis Stratified by Antifungal Therapy
por: Box, Maggie, et al.
Publicado: (2023)

Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis
por: Farahyar, Shirin, et al.
Publicado: (2020)

Species Distribution and Antifungal Susceptibility of Invasive Candidiasis: A 2016-2017 Multicenter Surveillance Study in Beijing, China
por: Guo, Li-Na, et al.
Publicado: (2020)

Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis
por: Tamai, Iradj Ashrafi, et al.
Publicado: (2021)

Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy
por: Cahan, Heather, et al.
Publicado: (2011)

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
por: do Couto, Fabíola Maria Marques, et al.
Publicado: (2016)

Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
por: Honarvar, Behnam, et al.
Publicado: (2018)

Antifungal Treatment is Not Required for Immunocompetent Individuals With Asymptomatic Esophageal Candidiasis
por: Min, Yang Won, et al.
Publicado: (2015)

Therapeutic tools for oral candidiasis: Current and new antifungal drugs
por: Quindós, Guillermo, et al.
Publicado: (2019)

The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
por: Ordaya, Eloy E., et al.
Publicado: (2023)

Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
por: Vergidis, Pascalis, et al.
Publicado: (2016)

Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
por: Shah, Neha, et al.
Publicado: (2017)

Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis
por: da Rosa Monte Machado, Gabriella, et al.
Publicado: (2020)

Cutaneous candidiasis in Tehran-Iran: from epidemiology to multilocus sequence types, virulence factors and antifungal susceptibility of etiologic Candida species
por: Sadeghi, Golnar, et al.
Publicado: (2019)

P048 Antifungal susceptibility and mechanism of azole resistance in Candida albicans clinical isolates from oropharyngeal candidiasis patients in Iran
por: Jahanshiri, Zahra
Publicado: (2022)

A study of the association between virulence factors and antifungal susceptibility profile of Candida species recovered from cases of vulvovaginal candidiasis
por: Siddiqui, Rafat, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1g238f00qto9om94nrcgd66h3f